Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q4 EPS of ($0.12), in-line with the analyst estimate of ($0.12).

For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.